UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drawing the line of ineligibility

Blood, 2018-06, Vol.131 (25), p.2739-2740

Kumar, Anita J.

2018

Volltextzugriff (PDF)

Time to diagnostic resolution after an uncertain screening mammogram in an underserved population

Cancer medicine (Malden, MA), 2020-05, Vol.9 (9), p.3252-3258

2020

Volltextzugriff (PDF)

Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice

Cancer, 2022-01, Vol.128 (2), p.222-229

2022

Volltextzugriff (PDF)

Adolescent and young adult cancer care: Financial hardship and continued uncertainty

Pediatric blood & cancer, 2019-04, Vol.66 (4), p.e27587-n/a

2019

Volltextzugriff (PDF)

Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects

Supportive care in cancer, 2022-02, Vol.30 (2), p.1399-1405

2022

Volltextzugriff (PDF)

Understanding treatment decisions for Hodgkin lymphoma: a qualitative study

Leukemia & lymphoma, 2023-12, Vol.64 (14), p.2249-2257

2023

Volltextzugriff (PDF)

First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study

British journal of haematology, 2020-07, Vol.190 (2), p.222-235

2020

Volltextzugriff (PDF)

Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making and Late Effects

Clinical lymphoma, myeloma and leukemia, 2022-01, Vol.22 (1), p.e65-e69

2022

Volltextzugriff (PDF)

Treatment patterns for relapsed and refractory Hodgkin lymphoma in a community oncology setting

Leukemia & lymphoma, 2022-04, Vol.63 (5), p.1119-1126

2022

Volltextzugriff (PDF)

Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists

Leukemia & lymphoma, 2021-01, Vol.62 (2), p.387-398

2021

Volltextzugriff (PDF)

Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report

Journal of geriatric oncology, 2021-06, Vol.12 (5), p.860-862

2021

Volltextzugriff (PDF)

Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper

Current hematologic malignancy reports, 2019-12, Vol.14 (6), p.523-535

2019

Volltextzugriff (PDF)

Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes

British journal of haematology, 2018-07, Vol.182 (2), p.212-221

2018

Volltextzugriff (PDF)

Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy

Journal of geriatric oncology, 2021-11, Vol.12 (8), p.1233-1239

2021

Volltextzugriff (PDF)

Chemotherapy is administered to a minority of hospitalized patients with diffuse large B-cell lymphoma and is associated with less likelihood of death during hospitalization

Cancer epidemiology, 2018-04, Vol.53, p.137-140

2018

Volltextzugriff (PDF)

Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML

Cancer medicine (Malden, MA), 2018-06, Vol.7 (6), p.2744-2752

2018

Volltextzugriff (PDF)

Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data

JCO clinical cancer informatics, 2022-05, Vol.6 (6), p.e2100135

2022

Volltextzugriff (PDF)

Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma

JAMA cardiology, 2023-05, Vol.8 (5), p.453

2023

Volltextzugriff (PDF)

Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma

JAMA network open, 2021-10, Vol.4 (10), p.e2128373-e2128373

2021

Volltextzugriff (PDF)

Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin Lymphoma

JACC CardioOncology, 2024-04, Vol.6 (2), p.200-213

2024

Volltextzugriff (PDF)

Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII

American journal of hematology, 2016-11, Vol.91 (11), p.1107-1112

2016

Volltextzugriff (PDF)

4129 Understanding Treatment Preferences for Hodgkin Lymphoma (HL) among Physicians, Patients and Caregivers

Journal of clinical and translational science, 2020-06, Vol.4 (s1), p.151-151

2020

Volltextzugriff (PDF)

3070 Time to Diagnostic Resolution After an Abnormal Screening Mammogram: a Single-Center Experience in an Underserved Hospital

Journal of clinical and translational science, 2019-03, Vol.3 (s1), p.97-97

2019

Volltextzugriff (PDF)

Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI

American journal of hematology, 2016-04, Vol.91 (4), p.426-429

2016

Volltextzugriff (PDF)

Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2013-07, Vol.19 (7), p.1094-1101

2013

Volltextzugriff (PDF)

1 – 25 von 538

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(475)
Mit Volltextzugriff
(457)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Drawing the line of ineligibility

Time to diagnostic resolution after an uncertain screening mammogram in an underserved population

Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice

Adolescent and young adult cancer care: Financial hardship and continued uncertainty

Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects

Understanding treatment decisions for Hodgkin lymphoma: a qualitative study

First‐line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)‐Medicare population‐based study

Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making and Late Effects

Treatment patterns for relapsed and refractory Hodgkin lymphoma in a community oncology setting

Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists

Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report

Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper

Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes

Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy

Chemotherapy is administered to a minority of hospitalized patients with diffuse large B-cell lymphoma and is associated with less likelihood of death during hospitalization

Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML

Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data

Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma

Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma

Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin Lymphoma

Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII

4129 Understanding Treatment Preferences for Hodgkin Lymphoma (HL) among Physicians, Patients and Caregivers

3070 Time to Diagnostic Resolution After an Abnormal Screening Mammogram: a Single-Center Experience in an Underserved Hospital

Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI

Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation

Suchergebnisse filtern